Literature DB >> 20587423

Autism in three patients with cystic or hyperechogenic kidneys and chromosome 17q12 deletion.

Chantal Loirat1, Christine Bellanné-Chantelot, Isabelle Husson, Georges Deschênes, Vincent Guigonis, Nadia Chabane.   

Abstract

BACKGROUND: We report autism in 3 out of 53 children with cystic or hyperechogenic kidneys and heterozygous 17q12 region deletion encompassing hepatocyte nuclear factor-1beta (HNF1B).
RESULTS: They presented mental retardation, social interaction impairments, verbal and non-verbal communication deficits and stereotyped behaviours. Deletion size and location of breakpoints were similar to those reported in patients with renal disease/diabetes only.
CONCLUSION: Reciprocal genomic rearrangements of the 17q12 region, reported in patients with mental retardation and epilepsy, could also be involved in autism. Nephrologists should be aware of the possibility of autism in patients with 17q12 deletion including HNF1B locus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587423     DOI: 10.1093/ndt/gfq380

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  30 in total

1.  Recurrent Transmission of a 17q12 Microdeletion and a Variable Clinical Spectrum.

Authors:  A M George; D R Love; I Hayes; B Tsang
Journal:  Mol Syndromol       Date:  2011-12-31

Review 2.  Hepatocyte Nuclear Factor 1β-Associated Kidney Disease: More than Renal Cysts and Diabetes.

Authors:  Jacobien C Verhave; Anneke P Bech; Jack F M Wetzels; Tom Nijenhuis
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 3.  Single-gene causes of congenital anomalies of the kidney and urinary tract (CAKUT) in humans.

Authors:  Asaf Vivante; Stefan Kohl; Daw-Yang Hwang; Gabriel C Dworschak; Friedhelm Hildebrandt
Journal:  Pediatr Nephrol       Date:  2014-01-08       Impact factor: 3.714

4.  Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia.

Authors:  Daniel Moreno-De-Luca; Jennifer G Mulle; Erin B Kaminsky; Stephan J Sanders; Scott M Myers; Margaret P Adam; Amy T Pakula; Nancy J Eisenhauer; Kim Uhas; LuAnn Weik; Lisa Guy; Melanie E Care; Chantal F Morel; Charlotte Boni; Bonnie Anne Salbert; Ashadeep Chandrareddy; Laurie A Demmer; Eva W C Chow; Urvashi Surti; Swaroop Aradhya; Diane L Pickering; Denae M Golden; Warren G Sanger; Emily Aston; Arthur R Brothman; Troy J Gliem; Erik C Thorland; Todd Ackley; Ram Iyer; Shuwen Huang; John C Barber; John A Crolla; Stephen T Warren; Christa L Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-11-04       Impact factor: 11.025

5.  Copy number variants: a new molecular frontier in clinical psychiatry.

Authors:  Daniel Moreno-De-Luca; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

Review 6.  HNF1B-associated clinical phenotypes: the kidney and beyond.

Authors:  Detlef Bockenhauer; Graciana Jaureguiberry
Journal:  Pediatr Nephrol       Date:  2015-07-08       Impact factor: 3.714

Review 7.  Developmental Genetics and Congenital Anomalies of the Kidney and Urinary Tract.

Authors:  Natalie Uy; Kimberly Reidy
Journal:  J Pediatr Genet       Date:  2015-09-07

8.  22q and two: 22q11.2 deletion syndrome and coexisting conditions.

Authors:  Jennifer L Cohen; Terrence B Crowley; Daniel E McGinn; Carey McDougall; Marta Unolt; Michele P Lambert; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-09-23       Impact factor: 2.802

Review 9.  Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options.

Authors:  May Sanyoura; Louis H Philipson; Rochelle Naylor
Journal:  Curr Diab Rep       Date:  2018-06-22       Impact factor: 4.810

Review 10.  Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence.

Authors:  Andres Moreno-De-Luca; Scott M Myers; Thomas D Challman; Daniel Moreno-De-Luca; David W Evans; David H Ledbetter
Journal:  Lancet Neurol       Date:  2013-03-18       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.